Prostate enlargement, which is called Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement and is common in ageing men. As the prostate enlarges, it compresses the urethra and interferes ...

Relief for men experiencing the challenges of Benign Prostatic Hyperplasia (BPH), or prostate enlargement, has arrived with the introduction of Flowel and Flowel Plus by Superior Pharmaceuticals ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

Add Yahoo as a preferred source to see more of our stories on Google. Giles Turner, from Brighton, is one of the men who could benefit from the drug Men with aggressive prostate cancer should be given ...

(MENAFN- EIN Presswire) EINPresswire/ -- The Prostate Cancer Drugs Market was valued at US$ 13.22 billion in 2024 and is projected to reach US$ 28.10 billion by 2033, growing at a CAGR of 8.1 percent ...